<?xml version="1.0" encoding="UTF-8"?>
<results title="testTrace">
 <result pre="(FDA) has remained relatively limited [11, 16]. Generally, the available" exact="treatment" post="strategies for emerging coronavirusâ€™ strains, that led to significant"/>
 <result pre="review is to evaluate the epigenetic mechanisms involved in HCoVsâ€™" exact="infection" post="and to highlight on epigenetic therapies in order to"/>
 <result pre="and cholangiocytes. Such cellular outspreading elucidates the consequences of SARS-CoV-2" exact="infection" post="that is not only limited to respiratory disorders but"/>
 <result pre="have been reported to be latency reversal agents in HIV" exact="infection" post="[39]. Nsp14, a 3â€²-5â€² exonuclease, is critical for coronavirus"/>
 <result pre="of new virions across the endoplasmic reticulum. SIRT1 activation following" exact="treatment" post="of the infected cells with resveratrol results in decreased"/>
 <result pre="it could anticipate novel-targeted strategies for the management of SARS-CoV-2" exact="infection" post="[52]. Antiviral therapies targeting the pathogen itself act by"/>
 <result pre="[16]. In the primary stages of SARS-CoV epidemic, an empirical" exact="treatment" post="of broad spectrum antiviral agents and immunosuppressive doses of"/>
 <result pre="immunosuppressive doses of steroids were used along with the supportive" exact="treatment" post="[53]. Despite the available treatment options, studies documenting the"/>
 <result pre="used along with the supportive treatment [53]. Despite the available" exact="treatment" post="options, studies documenting the therapiesâ€™ efficacy are lacking especially"/>
 <result pre="the SARS-CoV-2 outbreak [11, 54â€&quot;56]. Nevertheless, extending the choices of" exact="treatment" post="by generating epigenetic therapies would provide a real improvement"/>
 <result pre="Histone deacetylases (HDACs) resemble a main epigenetic target for the" exact="treatment" post="of viral infections [64, 65] (Fig. 1b). Hence, HDACs"/>
 <result pre="and DNA methyltransferase (DNMT)1 thus targeting the regulation of viral" exact="infection" post="[22, 57]. Significant downregulation of apoptosis induced by MERS-CoV,"/>
 <result pre="(SAHA), belinostat, romidepsin, and panobinostat were already used for the" exact="treatment" post="of several cancers such as T cell lymphoma and"/>
 <result pre="prior patient use [45]. Table 1 Epigenetics involved in coronavirus" exact="infection" post="and their therapeutic control Epigenetic drug target Antagonism â€œinhibitorsâ€�"/>
 <result pre="MZ1 Epigenetic regulation of cellular and immune landscape during coronavirus" exact="infection" post="Cellular and immune landscape during coronavirus infection In the"/>
 <result pre="landscape during coronavirus infection Cellular and immune landscape during coronavirus" exact="infection" post="In the course of viral infections, innate immune cells"/>
 <result pre="Toll-like receptor (TLR)4, TLR7, and TLR3/TIR-domain-containing adapter-inducing interferon-beta (TRIF) diminish" exact="infection" post="severity during HCoV infection in vivo. Moreover, interferons (IFN-alpha,"/>
 <result pre="and TLR3/TIR-domain-containing adapter-inducing interferon-beta (TRIF) diminish infection severity during HCoV" exact="infection" post="in vivo. Moreover, interferons (IFN-alpha, IFN-beta, IFN-gamma) which are"/>
 <result pre="open chromatin and promoting active transcription and ISG expression. MERS-CoV" exact="infection" post="of Calu3, a continuous human airway epithelial cell line,"/>
 <result pre="CXCL8, CXCL9, CXCL10) are upregulated by effector cells in SARS-CoV" exact="infection" post="linked with respiratory distress [14, 77â€&quot;79]. Unlike the proinflammatory"/>
 <result pre="lung of COVID-19 patients can also be shaped by SARS-CoV-2" exact="infection" post="of the airway epithelial cells. Thus, prominent epigenetic regulators"/>
 <result pre="proved a remarkable survival benefit in patients experiencing hyperinflammation post-SARS-CoV-2" exact="infection" post="[80, 81]. IFN-Î±Î² and IFN-Î³ inhibitors mitigate HCoV-induced inflammation;"/>
 <result pre="Belinostat and domatinostat enhanced the expression of TGF-Î² [58]. Moreover," exact="treatment" post="with TSA resulted in increased production of IL-10 [63,"/>
 <result pre="by â€œcomplementary exposureâ€� pattern, resulting in potential combination regimens for" exact="treatment" post="of HCoVs. To successfully inhibit MERS-CoV replication, kinase inhibitors"/>
 <result pre="no efficacy and high fatality rates were shown. Since ribavirin" exact="treatment" post="did not improve patient outcome health, Canada stopped permitting"/>
 <result pre="pegylated IFN-Î±2a for 2 weeks. At day 14 after confirmed" exact="diagnosis" post="of MERS, survival was increased in the tested group"/>
 <result pre="An ongoing randomized clinical trial in Saudi Arabia is evaluating" exact="treatment" post="of MERS patients with IFN-Î²1b conjointly with lopinavir/ritonavir due"/>
 <result pre="efficient amalgamation for treating HCoVs [4]. Knowing that the core" exact="treatment" post="for eradicating HCoVs is controlling replication and immune response,"/>
 <result pre="of CQ may play a crucial role in prevention and" exact="treatment" post="of COVID-19 as it operated at entry and post-entry"/>
 <result pre="as it operated at entry and post-entry phases of SARS-CoV-2" exact="infection" post="[16, 96â€&quot;98]. Generally, CQ blocks viral infection by elevating"/>
 <result pre="phases of SARS-CoV-2 infection [16, 96â€&quot;98]. Generally, CQ blocks viral" exact="infection" post="by elevating endosomal pH necessary for entry, replication, and"/>
 <result pre="prevention [99]. Conclusion and perspectives Providing more research to generate" exact="infection" post="control therapeutic interventions is a major challenge. The three"/>
 <result pre="originsEmerg Microbes Infect.2018720930531999 7.JossetLMenacheryVDGralinskiLEAgnihothramSSovaPCarter VS, et alCell host response to" exact="infection" post="with novel human coronavirus EMC predicts potential antivirals and"/>
 <result pre="and PI3k/Akt signaling pathways are required for establishing persistent SARS-CoV" exact="infection" post="in Vero E6 cellsBiochim Biophys Acta - Mol Basis"/>
 <result pre="and the challengesInt J Antimicrob Agents.20205510592432081636 14.LiXGengMPengYMengLLuSMolecular immune pathogenesis and" exact="diagnosis" post="of COVID-19J Pharm Anal.20201010210832282863 15.WHO. Coronavirus disease. World Health"/>
 <result pre="and oxidative stress survivalMol Cell Biol.201737e00214e0021728784718 51.LinSCHoCTChuoWHLiSWangTTLinCCEffective inhibition of MERS-CoV" exact="infection" post="by resveratrolBMC Infect Dis.20171714428193191 52.Taiaroa G, Rawlinson D, Featherstone"/>
 <result pre="Preprint at: http://biorxiv.org/lookup/doi/10.1101/2020.03.05.976167 (2020). 53.ChuCMChengVCCHungIFNWongMMLChanKHChanKSet al.Role of lopinavir/ritonavir in the" exact="treatment" post="of SARS: Initial virological and clinical findingsThorax.20045925225614985565 54.PeirisJSMYuenKYOsterhausADMEStÃ¶hrKThe Severe"/>
 <result pre="immunosuppressionThe Lancet.202039510331034 81.ZhangWZhaoYZhangFWangQLiTLiuZet al.The use of anti-inflammatory drugs in the" exact="treatment" post="of people with severe coronavirus disease 2019 (COVID-19): The"/>
 <result pre="COVID-19. Lancet Infect Dis. 2020;S1473309920302966. 97.SinghAKSinghAShaikhASinghRMisraAChloroquine and hydroxychloroquine in the" exact="treatment" post="of COVID-19 with or without diabetes: A systematic search"/>
 <result pre="and chronological aging: senolytics and other anti-aging drugs for the" exact="treatment" post="or prevention of corona virus infection?Aging.2020126511651732229706 100.LiJZhangCXLiuYMChenKLChenGA comparative study"/>
</results>
